Cargando…
Chemotherapy regimens in rare solid tumors /
Rare tumors are an increasing problem in oncology. Aim of this book is to offer a help in spreading the knowledge of low-incidence tumors in oncology. Each chapter provides brief information about the epidemiology of and clinical aspects for every RT; and, following each chemotherapy schedule, we re...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Torino :
SEEd Srl,
2011.
|
| Edición: | First edition. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Preface
- 1. Rare tumors of the thorax
- Mesothelioma
- Mesothelioma: Cisplatin + Pemetrexed
- Mesothelioma: Carboplatin + Pemetrexed
- Mesothelioma: Cisplatin + Gemcitabine
- Mesothelioma: Cisplatin + Doxorubicin
- Mesothelioma: Pemetrexed
- Mesothelioma: Pemetrexed + Gemcitabine
- Mesothelioma: Gemcitabine + Cisplatin
- Thymoma
- Thymoma: PAC
- Thymoma: PACE
- Thymoma: ADOC
- Thymoma: PE (EORTC)
- 2. Endocrine glands tumors
- Anaplastic thyroid carcinoma
- Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin
- Anaplastic thyroid carcinoma: Doxorubicin
- Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma
- Medullary thyroid carcinoma: CVD
- Medullary thyroid carcinoma: Sz/M
- Carcinoma of parathyroid
- Parathyroid carcinoma: CFuD
- Parathyroid carcinoma: Dacarbazine
- Adrenocortical carcinoma
- Adrenocortical carcinoma: Mitotane
- Adrenocortical carcinoma: EDP/M
- Adrenocortical carcinoma: EP + Mitotane
- Adrenocortical carcinoma: Sz/M
- Feocromocitoma
- Feocromocitoma: CVD
- 3. Neuroendocrine tumors
- Gastroenteropancreatic neuroendocrine tumors (GEP)
- GEP: Streptozotocin + Doxorubicin
- GEP: Streptozotocin + 5-Fluorouracil
- GEP: FDEGEP: IFN
- GEP: Octreotide LAR
- GEP: Lanreotide
- GEP: DTIC
- Poorly-differentiated neuroendocrine tumor of different sites
- Poorly-differentiated neuroendocrine tumor: PE
- Poorly-differentiated neuroendocrine tumor: CAV
- Poorly-differentiated neuroendocrine tumor: Topotecan
- Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin
- Poorly-differentiated neuroendocrine tumor: EC
- Poorly-differentiated neuroendocrine tumor: Etoposide orally
- Poorly-differentiated neuroendocrine tumor: PEC
- 4. Rare gynecological tumors
- Vulvar cancers
- Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy)
- Vulvar cancer: Cisplatin + Bleomycin
- Vulvar cancer: Cisplatin + 5-Fluorouracil
- Vulvar cancer: Cisplatin + Vinorelbine
- Uterine sarcomas
- Uterine sarcomas (Leiomyosarcoma): HD-IFO
- Uterine sarcomas (Leiomyosarcoma): Dacarbazine
- Uterine sarcomas (Leiomyosarcoma): Dacarbazine
- Uterine sarcomas (Leiomyosarcoma): Doxorubicin
- Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide
- Uterine sarcomas (Leiomyosarcoma): MAID
- Uterine sarcomas (Leiomyosarcoma): Trabectedin
- Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP
- Carcinosarcoma (mixed müllerian tumor): TAP
- Vaginal carcinoma
- Vaginal carcinoma: Cisplatin + Vinorelbine
- Vaginal carcinoma: Cisplatin + Bleomycin
- Vaginal carcinoma: BIP
- Vaginal carcinoma: BOMP
- Vaginal carcinoma: Cisplatin + 5-Fluorouracil
- Vaginal carcinoma: Cisplatin + Paclitaxel
- Vaginal carcinoma: Carboplatin + Paclitaxel
- 5. Rare tumors of male genital tract
- Testicular tumors and disgerminomas
- Testicular tumors and disgerminomas: BEP
- Testicular tumors: PVB
- 6. Sarcomas and GIST
- 7. Head and neck rare tumors
- 8. Gastrointestinal rare tumors
- 9. Raren tumors of the skin
- 10. Rare tumors of urniary tract
- References.